IL113926A - Contrast medium with improved patient's tolerance thereto and its use - Google Patents

Contrast medium with improved patient's tolerance thereto and its use

Info

Publication number
IL113926A
IL113926A IL11392695A IL11392695A IL113926A IL 113926 A IL113926 A IL 113926A IL 11392695 A IL11392695 A IL 11392695A IL 11392695 A IL11392695 A IL 11392695A IL 113926 A IL113926 A IL 113926A
Authority
IL
Israel
Prior art keywords
tolerance
use
contrast medium
improved patient
patient
Prior art date
Application number
IL11392695A
Other versions
IL113926D0 (en
Original Assignee
Korenstein Rafi
Dascalu Avi
Harel Avikam
Israel Humanitarian Foundation
Jade Holding Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korenstein Rafi, Dascalu Avi, Harel Avikam, Israel Humanitarian Foundation, Jade Holding Inc filed Critical Korenstein Rafi
Priority to IL11392695A priority Critical patent/IL113926A/en
Publication of IL113926D0 publication Critical patent/IL113926D0/en
Priority claimed from US08/952,954 external-priority patent/US6149891A/en
Publication of IL113926A publication Critical patent/IL113926A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0002General or multifunctional contrast agents, e.g. chelated agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0452Solutions, e.g. for injection
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
IL11392695A 1995-05-31 1995-05-31 Contrast medium with improved patient's tolerance thereto and its use IL113926A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL11392695A IL113926A (en) 1995-05-31 1995-05-31 Contrast medium with improved patient's tolerance thereto and its use

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
IL11392695A IL113926A (en) 1995-05-31 1995-05-31 Contrast medium with improved patient's tolerance thereto and its use
EP96916620A EP0863770A4 (en) 1995-05-31 1996-05-24 Contrast medium and its use
CA 2222429 CA2222429A1 (en) 1995-05-31 1996-05-24 Contrast medium and its use
AU59309/96A AU707118B2 (en) 1995-05-31 1996-05-24 Contrast medium and its use
US08/952,954 US6149891A (en) 1995-05-31 1996-05-24 X-ray contrast medium and method for protecting against harmful effects thereof
PCT/US1996/007666 WO1996038183A1 (en) 1995-05-31 1996-05-24 Contrast medium and its use

Publications (2)

Publication Number Publication Date
IL113926D0 IL113926D0 (en) 1995-08-31
IL113926A true IL113926A (en) 2000-06-01

Family

ID=11067540

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11392695A IL113926A (en) 1995-05-31 1995-05-31 Contrast medium with improved patient's tolerance thereto and its use

Country Status (5)

Country Link
EP (1) EP0863770A4 (en)
AU (1) AU707118B2 (en)
CA (1) CA2222429A1 (en)
IL (1) IL113926A (en)
WO (1) WO1996038183A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10115740A1 (en) 2001-03-26 2002-10-02 Ulrich Speck Preparation for the prophylaxis of restenosis
DE10244847A1 (en) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck A medical device for drug delivery

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2191118A (en) * 1937-06-03 1940-02-20 Firm Of N V Orgachemia Pyelographic preparation
US2870063A (en) * 1955-07-05 1959-01-20 Mallinckrodt Chemical Works X-ray contrast composition comprising substantially amylose-free amylopectin in aqueous solution of contrast agent
US3984571A (en) * 1970-03-10 1976-10-05 E. R. Squibb & Sons, Inc. Hydrocolloid containing liquid carrier for a diagnostic or therapeutic agent
US5847009A (en) * 1986-01-14 1998-12-08 Alliance Pharmaceutical Corp. Prophylaxis in the parenteral administration of particulate dispersions in fluorocarbon emulsions
USRE34077E (en) * 1988-05-02 1992-09-22 Cryomedical Sciences, Inc. Blood substitute
FR2635327B1 (en) * 1988-08-10 1990-11-16 Guerbet Sa Polymers iodine, a dextran skeleton, their processes of preparation and their applications as contrast agents
US5019370A (en) * 1989-07-10 1991-05-28 University Of Kentucky Research Foundation Biodegradable, low biological toxicity radiographic contrast medium and method of x-ray imaging
US5199951A (en) * 1990-05-17 1993-04-06 Wayne State University Method of drug application in a transporting medium to an arterial wall injured during angioplasty
US5334370A (en) * 1993-02-04 1994-08-02 Sterling Winthrop Inc. Compositions of alkylbenzenes in film-forming materials for visualization of the gastrointestinal tract
DE19518221A1 (en) * 1995-05-10 1996-11-14 Schering Ag Use of nonsteroidal anti-inflammatory drugs to improve the physiological compatibility particulate pharmaceutical preparations

Also Published As

Publication number Publication date
CA2222429A1 (en) 1996-12-05
WO1996038183A1 (en) 1996-12-05
EP0863770A1 (en) 1998-09-16
IL113926D0 (en) 1995-08-31
EP0863770A4 (en) 2001-01-10
AU5930996A (en) 1996-12-18
AU707118B2 (en) 1999-07-01

Similar Documents

Publication Publication Date Title
AU685134B2 (en) Dental syringe and cartridge therefor
GB2324734B (en) Catheter and needle assemblies
AU5607298A (en) Disposable pad and method
HU9904361A3 (en) Use of isobutylgaba and its derivatives for the treatment of pain
AU3943595A (en) An infusion and microdialysis pump
IL113901D0 (en) 1-phenyl-3-dimethylaminopropane compounds their preparation and use
AU3119495A (en) Surgical product and its use
NZ290219A (en) Osseointegration implant and its use in regenerating hard tissue
HK1049779A1 (en) Medical sensor and information system
RU96115107A (en) "human" antibodies and their use
AU692104B2 (en) Xanthines and their therapeutic use
EP0837933A4 (en) Optimized minizymes and miniribozymes and uses thereof
AU2103097A (en) Cinnoline derivatives and use as medicine
IL114352D0 (en) Catheter
EP0715863A3 (en) Catheter
AU2505795A (en) 1-arylpyrimidine derivatives and pharmaceutical use thereof
AU3955795A (en) Biocompatible coating, medical device using the same and methods
AU4405496A (en) Improved adenovirus and methods of use thereof
GR3032176T3 (en) Novel vehicle gases and their use in medical preparations.
PT850926E (en) Difluoroprostaglandine derivatives and their use
EP1011721A4 (en) Vaginal lactobacillus medicant
AU6738696A (en) Halobenzimidazoles and their use as microbicides
IL107081A (en) Azaquinoxalines and their use
AU5612794A (en) Medical instrument and procedure
PT749478E (en) Yeast stretches and modified albumines

Legal Events

Date Code Title Description
FF Patents granted
KB Patents renewed
MM9K Patent not in force due to non-payment of renewal fees